ING Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-7,940
Closed -$252K 678
2019
Q2
$252K Buy
7,940
+3
+0% +$89 ﹤0.01% 692
2019
Q1
$237K Buy
7,937
+6
+0.1% +$172 0.01% 654
2018
Q4
$245K Buy
7,931
+22
+0.3% +$803 0.01% 627
2018
Q3
$300K Sell
7,909
-220
-3% -$8.32K 0.01% 654
2018
Q2
$312K Buy
8,129
+61
+0.8% +$2.06K 0.01% 612
2018
Q1
$272K Buy
8,068
+65
+0.8% +$2.49K ﹤0.01% 639
2017
Q4
$355K Buy
8,003
+1,512
+23% +$68.9K 0.01% 607
2017
Q3
$325K Buy
6,491
+49
+0.8% +$2.5K 0.01% 671
2017
Q2
$340K Buy
+6,442
New +$345K 0.01% 648

Other funds holding PBH

ING Group's PBH Position: Q3 2019 in Review

ING Group sold out of Prestige Consumer Healthcare (PBH) in Q3 2019, closing a stake of 7,940 shares — an estimated $252K sold.

ING Group first reported a position in PBH in Q2 2017 and held it in 9 quarters. The position peaked at $355K in Q4 2017. 230 funds tracked by Wall St. Rank hold PBH as of Q3 2019.

  • ING Group reported no remaining Prestige Consumer Healthcare position as of Q3 2019 after selling out during the quarter.
  • ING Group sold 7,940 Prestige Consumer Healthcare shares in Q3 2019, an estimated $252K.
  • ING Group first reported a position in Prestige Consumer Healthcare in Q2 2017 and held it in 9 quarters.
  • ING Group's Prestige Consumer Healthcare position peaked at $355K in Q4 2017.
  • 230 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2019.

Based on ING Group's 13F filing for Q3 2019, filed 8 Nov 2019.